The aim of this study was to identify changes occurring from primary to recurrent HGSOC in tumour tissue expression of the angiogenesis-associated biomarkers CD31, applied for detecting microvessels density (MVD),9–11 and VEGF-A,12 by analysing a large cohort of paired primary and recurrent HGSOC tissue samples. This evidence concerns the gene VEGFA and neoplasm.